# A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease

> **NCT07168356** · PHASE1 · RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 32 (estimated)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Bepirovirsen

## Key facts

- **NCT ID:** NCT07168356
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-16
- **Primary completion:** 2026-04-28
- **Final completion:** 2026-08-18
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07168356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07168356, "A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07168356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*